Home › Startup funding (SEC Form D)
Latest Form D filings: biotech startups
Biotechnology companies that filed a new Form D (notice of an exempt private securities offering) with the SEC in the last 7 days.
Get the full list or daily alerts as CSV / Excel / JSON. This page shows a weekly snapshot. Our SEC Form D Startup Funding Leads on Apify runs the same search on demand or on a schedule, returns every match (with only-new-since-last-run alerts) and exports to CSV, Excel, JSON or Google Sheets. Pay per result; Apify's free plan includes monthly usage credit.
Get the full list on Apify →
Get the full list on Apify →
Use this exact search (Actor input)
{
"industryGroups": [
"Biotechnology"
],
"filedWithinDays": 7
}| Company (issuer) | Industry | Location | Inc. year | Offering | Sold so far | Filed |
|---|---|---|---|---|---|---|
| Conexeu Sciences Inc. Corporation · Equity, Option/warrant/right, Security to be acquired on exercise | Biotechnology | RENO, NV | 2022 | $2,999,994 | $1,499,997 | 2026-10-21 |
| Quiver Holdings Inc. Corporation · Debt, Option/warrant/right, Security to be acquired on exercise | Biotechnology | CAMBRIDGE, MA | 2023 | Indefinite | $3,005,000 | 2026-10-21 |
| Trellis Bioscience, Inc. Corporation · Equity, Option/warrant/right, Other: Series B Interests | Biotechnology | Redwood City, CA | Indefinite | $22,892,056 | 2026-10-21 | |
| Trellis Bioscience, Inc. Corporation · Equity, Option/warrant/right, Other: Series 2022 Bridge. Includes convertible notes with 20% warrant coverage. | Biotechnology | Redwood City, CA | Indefinite | $985,000 | 2026-10-21 | |
| Trellis Bioscience, Inc. Corporation · Equity, Option/warrant/right, Other: Series 2023 Bridge. Includes convertible notes with 20% warrant coverage. | Biotechnology | Redwood City, CA | Indefinite | $1,350,000 | 2026-10-21 | |
| Trellis Bioscience, Inc. Corporation · Equity, Option/warrant/right, Other: Series 2024 Bridge. Includes convertible notes with 20% warrant coverage. | Biotechnology | Redwood City, CA | Indefinite | $4,094,500 | 2026-10-21 | |
| Adela, Inc. Corporation · Debt, Other: Convertible promissory notes convertible into equity securities of the Issuer and the equity securities to be issued upon such conversion | Biotechnology | FOSTER CITY, CA | $12,000,000 | $12,000,000 | 2026-10-19 | |
| Theravie Pharma, Inc. Corporation · Equity, Other: Simple Agreement for Future Equity (SAFE), a contractual right to receive equity securities upon the occurrence of specified future financing events. | Biotechnology | SAN DIEGO, CA | 2025 | $2,250,000 | $750,000 | 2026-10-19 |
| Alercell Inc Corporation · Equity | Biotechnology | BOZEMAN, US, MT | $1,500,000 | $35,000 | 2026-10-19 | |
| Estuary Biotherapeutics, Inc. Corporation · Equity | Biotechnology | MENLO PARK, CA | 2022 | $103,654,385 | $40,654,685 | 2026-10-16 |
| Immorta Bio, Inc. Corporation · Equity | Biotechnology | MIAMI BEACH, FL | 2023 | $5,000,000 | $612,503 | 2026-10-16 |
About this data
Data: SEC EDGAR Form D filings (U.S. Securities and Exchange Commission), public information. Only issuer (company) data is shown; related persons and signatories are not published here.
Related searches
- Latest Form D filings: tech startups
- Latest Form D filings: healthcare and pharma companies
- Latest Form D filings: energy and cleantech companies
- Latest Form D filings: real estate offerings
- New Form D filings by California startups
- New Form D filings by New York startups
- New Form D filings by Texas startups
- Young companies raising US$1M+ (Form D, last 7 days)